CoChat

Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling

Open access
Lamb, Rebecca, Bonuccelli, Gloria, Ozsvári, Béla, Peiris-Pagès, Maria, Fiorillo, Marco, Smith, Duncan L., Bevilacqua, Generoso, Mazzanti, Chiara Maria, McDonnell, Liam A., Naccarato, Antonio Giuseppe, Chiu, Maybo, Wynne, Luke, Martinez-Outschoorn, Ubaldo E., Sotgia, Federica, Lisanti, Michael P. · 2015 · Oncotarget
Cited by 145

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

// Rebecca Lamb 1,2,* , Gloria Bonuccelli 1,2,* , Béla Ozsvári 1,2 , Maria Peiris-Pagès 1,2 , Marco Fiorillo 1,2,3 , Duncan L. Smith 4 , Generoso Bevilacqua 5,6 , Chiara Maria Mazzanti 5 , Liam A. McDonnell 5 , Antonio Giuseppe Naccarato 6 , Maybo Chiu 1,2 , Luke Wynne 1,2 , Ubaldo E. Martinez-Outschoorn 7 , Federica Sotgia 1,2 and Michael P. Lisanti 1,2 1 The Breast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Manchester, UK 2 The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, University of Manchester, Manchester, UK 3 The Department of Pharmacy, Health and Nutritional Sciences, The University of Calabria, Cosenza, Italy 4 The Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK 5 FPS – The Pisa Science Foundation, Pisa, Italy 6 Department of Pathology, Pisa University Hospital, Pisa, Italy 7 The Sidney Kimmel Cancer Center, Philadelphia, PA, USA * These authors should be considered as co-first authors Correspondence to: Michael P. Lisanti, email: // Federica Sotgia, email: // Keywords : mitochondria, MitoTracker, MMTV, WNT, FGF Received : July 21, 2015 Accepted : August 22, 2015 Published : September 28, 2015 Abstract Here, we developed an isogenic cell model of “stemness” to facilitate protein biomarker discovery in breast cancer. For this purpose, we used knowledge gained previously from the study of the mouse mammary tumor virus (MMTV). MMTV initiates mammary tumorigenesis in mice by promoter insertion adjacent to two main integration sites, namely Int-1 (Wnt1) and Int-2 (Fgf3), which ultimately activates Wnt/β-catenin signaling, driving the propagation of mammary cancer stem cells (CSCs). Thus, to develop a humanized model of MMTV signaling, we over-expressed WNT1 and FGF3 in MCF7 cells, an ER(+) human breast cancer cell line. We then validated that MCF7 cells over-expressing both WNT1 and FGF3 show a 3.5-fold increase in mammosphere formation, and that conditioned media from these cells is also sufficient to promote stem cell activity in untransfected parental MCF7 and T47D cells, as WNT1 and FGF3 are secreted factors. Proteomic analysis of this model system revealed the induction of i) EMT markers, ii) mitochondrial proteins, iii) glycolytic enzymes and iv) protein synthesis machinery, consistent with an anabolic CSC phenotype. MitoTracker staining validated the expected WNT1/FGF3-induced increase in mitochondrial mass and activity, which presumably reflects increased mitochondrial biogenesis. Importantly, many of the proteins that were up-regulated by WNT/FGF-signaling in MCF7 cells, were also transcriptionally over-expressed in human breast cancer cells in vivo , based on the bioinformatic analysis of public gene expression datasets of laser-captured patient samples. As such, this isogenic cell model should accelerate the discovery of new biomarkers to predict clinical outcome in breast cancer, facilitating the development of personalized medicine. Finally, we used mitochondrial mass as a surrogate marker for increased mitochondrial biogenesis in untransfected MCF7 cells. As predicted, metabolic fractionation of parental MCF7 cells, via MitoTracker staining, indicated that high mitochondrial mass is a new metabolic biomarker for the enrichment of anabolic CSCs, as functionally assessed by mammosphere-forming activity. This observation has broad implications for understanding the role of mitochondrial biogenesis in the propagation of stem-like cancer cells. Technically, this general metabolic approach could be applied to any cancer type, to identify and target the mitochondrial-rich CSC population. The implications of our work for understanding the role of mitochondrial metabolism in viral oncogenesis driven by random promoter insertions are also discussed, in the context of MMTV and ALV infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.5852

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 145

Metadata

Authors
Lamb, R., Bonuccelli, G., Ozsvári, B., Peiris-Pagès, M., Fiorillo, M., Smith, D. L., Bevilacqua, G., Mazzanti, C. M., McDonnell, L. A., Naccarato, A. G., Chiu, M., Wynne, L., Martinez-Outschoorn, U. E., Sotgia, F., & Lisanti, M. P.
Venue
Oncotarget
Published
2015-09-28
Volume
6
Issue
31
Pages
30453-30471
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2153597782
Cited by
145
References
4
FWCI
4.91
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.